Cargando…

Why the complications of COVID-19 patients differ in elderly and young cancer patients

Zhang et al. reported the impact of different risk factors and comorbidities in COVID-19 lethality. The authors observed that the odds of dying by COVID-19 in cancer patients decrease with age and cancer becomes a non-significant factor above 80 years. We speculate on the possible causes for the dif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bravaccini, Sara, Nicolini, Fabio, Zanoni, Michele, Gaimari, Anna, Cerchione, Claudio, Maltoni, Roberta, Pirini, Francesca, Mazzotti, Lucia, Cortesi, Michela, Ravaioli, Sara, Tumedei, Maria Maddalena, Mazza, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2022
Materias:	Spotlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464575/ https://www.ncbi.nlm.nih.gov/pubmed/36119944 http://dx.doi.org/10.1016/j.tranon.2022.101541

Ejemplares similares

Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?
por: Maltoni, Roberta, et al.
Publicado: (2021)

Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota
por: Pirini, Francesca, et al.
Publicado: (2023)

Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
por: Cortesi, Michela, et al.
Publicado: (2021)

ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
por: Ravaioli, Sara, et al.
Publicado: (2020)

Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold
por: Maltoni, Roberta, et al.
Publicado: (2020)

Androgen receptor in breast cancer: The “5W” questions
por: Ravaioli, Sara, et al.
Publicado: (2022)

T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer
por: Mazzotti, Lucia, et al.
Publicado: (2022)

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer
por: Maltoni, Roberta, et al.
Publicado: (2020)

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience
por: Palleschi, Michela, et al.
Publicado: (2020)

The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects
por: Bravaccini, Sara, et al.
Publicado: (2021)

Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology
por: Ravaioli, Sara, et al.
Publicado: (2016)

Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer
por: Maltoni, Roberta, et al.
Publicado: (2017)

Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon
por: Martino, Massimo, et al.
Publicado: (2022)

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?
por: Bronte, Giuseppe, et al.
Publicado: (2018)

Leadless pacemaker implantation in elderly patients with abandoned transvenous pacemakers with depleted batteries
por: Frick, William, et al.
Publicado: (2023)

Spotlight on PSMA as a new theranostic biomarker for bladder cancer
por: Tumedei, Maria Maddalena, et al.
Publicado: (2021)

Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?
por: Bravaccini, Sara, et al.
Publicado: (2018)

Are changes in the gut microbiome a contributor or consequence of autism—why not both?
por: Özcan, Ezgi, et al.
Publicado: (2022)

Complete revascularization in elderly patients with myocardial infarction—a safe, effective, and necessary strategy?
por: Gue, Ying X., et al.
Publicado: (2023)

Why has the incidence of tuberculosis not reduced in London during the COVID-19 pandemic?
por: Lewer, Dan, et al.
Publicado: (2022)

The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial
por: Bravaccini, Sara, et al.
Publicado: (2020)

Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival
por: Tumedei, Maria Maddalena, et al.
Publicado: (2023)

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
por: Bravaccini, Sara, et al.
Publicado: (2019)

Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
por: Bravaccini, Sara, et al.
Publicado: (2021)

Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer
por: Maltoni, Roberta, et al.
Publicado: (2022)

What Influences the Choice of Ibrutinib–Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia?
por: Bravaccini, Sara, et al.
Publicado: (2020)

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
por: Bronte, Giuseppe, et al.
Publicado: (2018)

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
por: Bronte, Giuseppe, et al.
Publicado: (2019)

With a little help from my T friends: T cells increase efficacy of KRAS (G12D) inhibitors
por: Mainardi, Sara
Publicado: (2023)

Predictive Role of Telomerase Activity in the Clinical Outcome of Patients with Benign Lesions of the Uterine Cervix or CIN
por: Bravaccini, Sara, et al.
Publicado: (2012)

Estrogen and Androgen Receptor Inhibitors: Unexpected Allies in the Fight Against COVID-19
por: Bravaccini, Sara, et al.
Publicado: (2021)

High fat stems tumor immune surveillance
por: Caruso, Roberta, et al.
Publicado: (2021)

The road ahead for chronic headache patients
por: Martelletti, P.
Publicado: (2006)

PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis
por: Bravaccini, Sara, et al.
Publicado: (2018)

Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ
por: Farolfi, Alberto, et al.
Publicado: (2020)

Cancer Patients and Risk of Mortality for COVID-19
por: Curigliano, Giuseppe
Publicado: (2020)

Expanding Roles of De Novo Lipogenesis in Breast Cancer
por: Simeone, Pasquale, et al.
Publicado: (2021)

Coronavirus epidemic: preparing for extracorporeal organ support in intensive care
por: Ronco, Claudio, et al.
Publicado: (2020)

SPIN(DLY)-OFF: A tale of conformational change to control DYNEIN
por: Barbosa, João, et al.
Publicado: (2022)

Patient collaboration in COVID-19 research: translating ideas to reality
por: Kirby, Tony
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8vfjn1e6k9jrvlvqqbdois40ap